Carl Icahn
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6402998
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6402984
Carl Icahn continues to increase his position in Lions Gate Entertainment (NYSE: LGF) ...
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6400247
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6398079
-
Pali Capital Expands High Yield Effort in New York
-
Golden Phoenix Minerals Appoints Clyde Harrison to Its Board of Directors
-
Icahn Pounding the Table on Lions Gate (LGF), Buys Another 500K Shares
-
After-Hours Movers 6/17: LVLT, LGF, SIRI, AZO Higher; IMGN, SOA, HPT, CLC Lower
-
Carl Icahn Bought Over 1M More Lions Gate (LGF) Shares Today
-
Form SC 13D/A LIONS GATE ENTERTAINMENT Filed by: ICAHN CARL C
-
Form 4 LIONS GATE ENTERTAINMENT For: Jun 17 Filed by: ICAHN CARL C
-
Carl Icahn Continues To Buy Lions Gate Entertainment (LGF)
-
Form 4 LIONS GATE ENTERTAINMENT For: Jun 12 Filed by: ICAHN PARTNERS MASTER FUND III L.P.
-
Sanofi-Aventis (SNY) On the Prowl For A Mega-Deal In the U.S.?
-
Bankruptcy Judge Approves Sale of Tropicana Casino To Icahn Group
-
Form 4 LIONS GATE ENTERTAINMENT For: Jun 09 Filed by: ICAHN CARL C
-
Carl C. Icahn Pleased With Results of Biogen Election
-
Form 4 LIONS GATE ENTERTAINMENT For: Jun 03 Filed by: ICAHN CARL C
-
Form SC 13D/A LIONS GATE ENTERTAINMENT Filed by: ICAHN CARL C
-
Icahn Says Future Is Big Pharma Will Buy Biotech (BIIB, AMLN)
-
Icahn's Group Reportedly To Get 2 of The 4 Biogen Idec (BIIB) Board Seats
-
Icahn Indicates That Biogen Board Refuses To Close Polls
-
Icahn To File Lawsuit To Stop Biogen Idec (BIIB) Vote
-
Biogen Idec (BIIB) Shareholder Meeting In Recess, Icahn Wants Vote Closed
-
Amylin (AMLN) Reports Preliminary Tabulation of Annual Meeting Results
-
Amylin Announces Preliminary Tabulation of Annual Meeting Results
-
RiskMetrics Supports Two From Icahn Slate For Biogen Idec (BIIB) Board
-
ISS Supports Icahn Nominees for Biogen Idec Board
-
Amylin (AMLN) Said No More Than Two Dissident Directors Elected
-
Amylin Announces Preliminary Results of Annual Meeting of Stockholders
-
Amylin (AMLN) Has Lost At Least 2 Board Seats in Battle with Icahn -CNBC
-
Eastbourne Comments on Election of Directors at Amylin Annual Meeting of Shareholders
-
NFL Veteran Wayne Chrebet Joins Morgan Stanley's Red Bank, NJ Office
-
Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today
-
Biogen Idec Sends Letter to Stockholders
-
Eastbourne Calls on All Amylin Shareholders to Vote Today and Support Change to the Amylin Board of Directors
-
Biogen (BIIB) Advisors Recommend Not Voting for Icahn's Slate of Directors
-
Biogen Idec Comments on Proxy Advisory Firms' Reports
-
Form 8-K ICAHN ENTERPRISES L.P. For: May 22
-
Eastbourne Calls on Amylin Employees to Help Shape the Company's Future and Support Change to the Board
-
Fourth Independent Proxy Advisory Firm Recommends Change to Board of Directors at Amylin Pharmaceuticals
-
Amylin (AMLN) Issues Response to Eastbourne Letter
-
Amylin Responds to Eastbourne Letter
-
Eastbourne Sends Letter to Amylin Board
-
Icahn Urges Amylin (AMLN) Shareholders to Vote for Eastbourne Slate; 3 Independent Proxy Advisors Support Icahn's Nominees
-
Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
-
Form 4 ICAHN ENTERPRISES L.P. For: May 14 Filed by: ICAHN CARL C
-
Eastbourne Capital Sends Letter to Amylin Shareholders Outlining Broad Call for Change to Amylin Board
-
Three Leading Independent Proxy Advisory Firms Now Support Change at Amylin Pharmaceuticals
-
Amylin Comments on RiskMetrics Report
-
RiskMetrics Supports Change to the Board of Directors at Amylin
-
Icahn Boosts Stake in American Railcar (ARII), Maintains Large Yahoo! (YHOO) and Motorola (MOT) Holdings
-
Icahn Capital: Sells - APC, TIN, WMB; Buys - LGF, TTWO, AMLN
-
Carl Icahn raises stake in American Railcar Industries (Nasdaq: ARII), Lions Gate (NYSE: LGF) - 13F
